Name: Latest research reports of Dixon Technologies (India) Ltd. authored by Dolat Capital and published by - Trendlyne research reports.
Item: Dixon Technologies (India) Ltd.
Rating: 5
Author: Dolat Capital

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	16 Oct 2020	Dixon Technologies	Dolat Capital Reco Target	16591.00	10700.00	9261.70 (79.14%)	Target met	Buy	pdf post cache	Broker Report Dixon Technolog Dolat Capital pdf Copy Link Share on Share on Share on Share on Alert
	15 Oct 2020	Infosys	Dolat Capital Reco Target	1446.60	1270.00	1108.25 (30.53%)	Target met	Accumulate	pdf post cache	Broker Report Infosys Dolat Capital pdf Copy Link Share on Share on Share on Share on Alert
	14 Oct 2020	Wipro	Dolat Capital	240.98	320.00	350.45 (-31.24%)	Pre-Bonus/ Split	Sell	pdf post cache	Broker Report Wipro Dolat Capital pdf Copy Link Share on Share on Share on Share on Alert
	09 Oct 2020	Aurum Proptech	Dolat Capital Reco Target	168.54	851.00	876.95 (-80.78%)	Target met	Accumulate	pdf post cache	Broker Report Majesco Dolat Capital pdf Copy Link Share on Share on Share on Share on Alert
	08 Oct 2020	Amber Enterprises	Dolat Capital	8214.50	1900.00	1954.65 (320.25%)	Target met	Sell	pdf post cache	Broker Report Amber Enterpris Dolat Capital pdf Copy Link Share on Share on Share on Share on Alert
	08 Oct 2020	Brokerage Research Reports	Dolat Capital					Buy	pdf post cache	Broker Report Intellect Desig Dolat Capital pdf Copy Link Share on Share on Share on Share on Alert
	01 Oct 2020	Gujarat Gas	Dolat Capital Reco Target	436.65	360.00	312.85 (39.57%)	Target met	Accumulate	pdf post cache	Broker Report Gujarat Gas Dolat Capital Volumes were at 906 mmscm which was an increase of 5.4%YoY and of 140% QoQ, with industrial segment growth at 9% YoY and 178% QoQ. Sales from the industrial segment is currently above Pre Covid levels as their sales volume has shown robust recovery post lockdown. Realisations declined sequentially by 3.4% to Rs 28.3/scm as price reduction were taken in industrial segment to compete with alternate... pdf Copy Link Share on Share on Share on Share on Alert
	22 Sep 2020	JBM Auto	Dolat Capital Target	682.80	373.00	216.10 (215.96%)	Target met	Buy	pdf post cache	Broker Report JBM Auto Dolat Capital JBM Auto (JBMA) reported in line performance in 1QFY21. Net revenue declined 75% YoY to Rs 1.3bn (vs est. Rs 1.37bn) led by de-growth in component and tooling division (-86%/-37% YoY)... pdf Copy Link Share on Share on Share on Share on Alert
	21 Sep 2020	Sun Pharmaceutical	Dolat Capital Target	1631.20	660.00	503.65 (223.88%)	Target met	Buy	pdf post cache	Broker Report Sun Pharma Dolat Capital Given the structural headwinds in the US faced by Indian generic companies, Sun's investments to build a branded specialty business is a key differentiator. However, Specialty pharma is a vastly different business model compared to traditional generics requiring significantly... pdf Copy Link Share on Share on Share on Share on Alert
	18 Sep 2020	Dr. Reddy's Labs	Dolat Capital	1248.10		5333.35 (-76.60%)	Pre-Bonus/ Split	Buy	pdf post cache	Broker Report Dr Reddys Labs Dolat Capital Dr Reddy's settles with BMS on multiple myeloma drug, Revlimid for a limited volume launch during FY23-26, post which the volume cap will be lifted. Dr Reddy's is the third company to settle post Natco and Alvogen, though details of the settlement term are not known yet. The key... pdf Copy Link Share on Share on Share on Share on Alert
more loading

Dolat Capital Broker Research reports

Latest broker research reports from Dolat Capital buy, sell, hold, neutral recommendations along with share price targets forecast and upside.

Dixon Technolog

Infosys

Wipro

Majesco

Amber Enterpris

Intellect Desig

Gujarat Gas

JBM Auto

Sun Pharma

Dr Reddys Labs

Advisor Screeners